Cushing's syndrome

BMJ (Online)

Volumn 346, Issue 7901, 2013, Pages

  Prague, Julia Kate ^a   May, Stephanie ^b   Whitelaw, Benjamin Cameron ^a  

^a KING S COLLEGE HOSPITAL   (United Kingdom)

^b Stockwell Group Practice   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; AWARENESS; CLINICAL FEATURE; CUSHING SYNDROME; DELAYED DIAGNOSIS; DISEASE ASSOCIATION; DISEASE COURSE; HUMAN; LABORATORY TEST; MEDICAL HISTORY; MORTALITY; PATHOPHYSIOLOGY; PATIENT CARE; PHYSICAL EXAMINATION; PRIORITY JOURNAL;

CUSHING SYNDROME; DELAYED DIAGNOSIS; DIABETES COMPLICATIONS; FEMALE; GLUCOCORTICOIDS; HUMANS; HYDROCORTISONE; MIDDLE AGED;

EID: 84875831653     PISSN: None     EISSN: 17561833     Source Type: Journal    
DOI: 10.1136/bmj.f945     Document Type: Article

References (17)

1. Fardet L, Petersen I, Nazareth I. Risk of cardiovascular events in people prescribed glucocorticoids with iatrogenic Cushing's syndrome: cohort study. BMJ 2012;345:e4928.
2. Tempark T, Phatarakijnirund V, Chatproedprai S, Watcharasindhu S, Supornsilchai V, Wananukul S. Exogenous Cushing's syndrome due to topical corticosteroid application: case report and review literature. Endocrine 2010;38:328-34.
3. Fardet L, Flahault A, Kettaneh A, Tiev KP, Genereau T, Toledano C, et al. Corticosteroid-induced clinical adverse events: frequency, risk factors and patient's opinion. Br J Dermatol 2007;157:142-8.
4. Lindholm J, Juul S, Jorgensen JO, Astrup J, Bjerre P, Feldt-Rasmussen U, et al. Incidence and late prognosis of Cushing's syndrome: a population-based study. J Clin Endocrinol Metab 2001;86:117-23.
5. Terzolo M, Reimondo G, Chiodini I, Castello R, Giordano R, Ciccarelli E, et al. Screening of Cushing's syndrome in outpatients with type 2 diabetes: results of a prospective multicentric study in Italy. J Clin Endocrinol Metab 2012;97:3467-75.
6. Anderson GH Jr, Blakeman N, Streeten DH. The effect of age on prevalence of secondary forms of hypertension in 4429 consecutively referred patients. J Hypertens 1994;12:609-15.
7. Newell-Price J, Bertagna X, Grossman AB, Nieman LK. Cushing's syndrome. Lancet 2006;367:1605-17.
8. Psaras T, Milian M, Hattermann V, Freiman T, Gallwitz B, Honegger J. Demographic factors and the presence of comorbidities do not promote early detection of Cushing's disease and acromegaly. Experimental and Clinical Endocrinology & Diabetes 2011;119(1):21-5.
9. Ross EJ, Linch DC. Cushing's syndrome-killing disease: discriminatory value of signs and symptoms aiding early diagnosis. Lancet 1982;2:646-9.
10. Plotz CM, Knowlton AI, Ragan C. The natural history of Cushing's syndrome. Am J Med 1952;13:597-614.
11. Clayton RN, Raskauskiene D, Reulen RC, Jones PW. Mortality and morbidity in Cushing's disease over 50 years in Stoke-on-Trent, UK: audit and meta-analysis of literature. J Clin Endocrinol Metab 2011;96:632-42.
12. Nieman LK, Biller BM, Findling JW, Newell-Price J, Savage MO, Stewart PM, et al. The diagnosis of Cushing's syndrome: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 2008;93:1526-40.
13. Pecori Giraldi F, Ambrogio AG, de Martin M, Fatti LM, Scacchi M, Cavagnini F. Specificity of first-line tests for the diagnosis of Cushing's syndrome: assessment in a large series. J Clin Endocrinol Metab 2007;92:4123-9.
14. Findling JW, Raff H. Screening and diagnosis of Cushing's syndrome. Endocrinol Metab Clin North Am 2005;34:385-402, ix-x.
15. Reimondo G, Allasino B, Bovio S, Paccotti P, Angeli A, Terzolo M. Evaluation of the effectiveness of midnight serum cortisol in the diagnostic procedures for Cushing's syndrome. Eur J Endocrinol 2005;153:803-9.
16. Wood PJ, Barth JH, Freedman DB, Perry L, Sheridan B. Evidence for the low dose dexamethasone suppression test to screen for Cushing's syndrome-recommendations for a protocol for biochemistry laboratories. Ann Clin Biochem 1997;34(part 3):222-9.
17. Gold PW, Goodwin FK, Chrousos GP. Clinical and biochemical manifestations of depression. Relation to the neurobiology of stress (2). N Engl J Med 1988;319:413-20.